BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32945485)

  • 21. Human cytomegalovirus induces cellular tyrosine kinase signaling and promotes glioma cell invasiveness.
    Cobbs CS; Soroceanu L; Denham S; Zhang W; Britt WJ; Pieper R; Kraus MH
    J Neurooncol; 2007 Dec; 85(3):271-80. PubMed ID: 17589804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Inhibition of miR-144-3p on Cell Proliferation and Metastasis by Targeting TOP2A in HCMV-Positive Glioblastoma Cells.
    Song J; Ma Q; Hu M; Qian D; Wang B; He N
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30544723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HCMV glycoprotein B is expressed in primary glioblastomas and enhances growth and invasiveness via PDGFR-alpha activation.
    Cobbs C; Khan S; Matlaf L; McAllister S; Zider A; Yount G; Rahlin K; Harkins L; Bezrookove V; Singer E; Soroceanu L
    Oncotarget; 2014 Feb; 5(4):1091-100. PubMed ID: 24658280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human Cytomegalovirus IE2 Protein Disturbs Brain Development by the Dysregulation of Neural Stem Cell Maintenance and the Polarization of Migrating Neurons.
    Han D; Byun SH; Kim J; Kwon M; Pleasure SJ; Ahn JH; Yoon K
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28615204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of human cytomegalovirus immediate-early proteins in cell growth control.
    Castillo JP; Yurochko AD; Kowalik TF
    J Virol; 2000 Sep; 74(17):8028-37. PubMed ID: 10933712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of GFAP, TSP-1, and p53 in human glioblastoma cell line, U373MG, by IE1 protein from human cytomegalovirus.
    Lee K; Jeon K; Kim JM; Kim VN; Choi DH; Kim SU; Kim S
    Glia; 2005 Jul; 51(1):1-12. PubMed ID: 15779089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections.
    Tavalai N; Papior P; Rechter S; Leis M; Stamminger T
    J Virol; 2006 Aug; 80(16):8006-18. PubMed ID: 16873257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The human cytomegalovirus IE2 and UL112-113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs or ND10).
    Ahn JH; Jang WJ; Hayward GS
    J Virol; 1999 Dec; 73(12):10458-71. PubMed ID: 10559364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human cytomegalovirus IE1 protein enhances herpes simplex virus type 1-induced syncytial formation in U373MG cells.
    Shin KC; Park CG; Hwang ES; Cha CY
    J Korean Med Sci; 2008 Dec; 23(6):1046-52. PubMed ID: 19119451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional regulation of the structure-specific endonuclease FEN1 by the human cytomegalovirus protein IE1 suggests a role for the re-initiation of stalled viral replication forks.
    Schilling EM; Scherer M; Rothemund F; Stamminger T
    PLoS Pathog; 2021 Mar; 17(3):e1009460. PubMed ID: 33770148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human cytomegalovirus riding the cell cycle.
    Spector DH
    Med Microbiol Immunol; 2015 Jun; 204(3):409-19. PubMed ID: 25776080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human cytomegalovirus IE1-72 activates ataxia telangiectasia mutated kinase and a p53/p21-mediated growth arrest response.
    Castillo JP; Frame FM; Rogoff HA; Pickering MT; Yurochko AD; Kowalik TF
    J Virol; 2005 Sep; 79(17):11467-75. PubMed ID: 16103197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human cytomegalovirus IE1 protein alters the higher-order chromatin structure by targeting the acidic patch of the nucleosome.
    Fang Q; Chen P; Wang M; Fang J; Yang N; Li G; Xu RM
    Elife; 2016 Jan; 5():. PubMed ID: 26812545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophage cultures are susceptible to lytic productive infection by endothelial-cell-propagated human cytomegalovirus strains and present viral IE1 protein to CD4+ T cells despite late downregulation of MHC class II molecules.
    Sinzger C; Eberhardt K; Cavignac Y; Weinstock C; Kessler T; Jahn G; Davignon JL
    J Gen Virol; 2006 Jul; 87(Pt 7):1853-1862. PubMed ID: 16760387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Digitoxin Suppresses Human Cytomegalovirus Replication via Na
    Mukhopadhyay R; Venkatadri R; Katsnelson J; Arav-Boger R
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29321306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Host Factors Involved in Human Cytomegalovirus Replication, Assembly, and Egress Using a Two-Step Small Interfering RNA Screen.
    McCormick D; Lin YT; Grey F
    mBio; 2018 Jun; 9(3):. PubMed ID: 29946045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5‑Azacytidine treatment results in nuclear exclusion of DNA methyltransferase‑1, as well as reduced proliferation and invasion in human cytomegalovirus‑infected glioblastoma cells.
    Estekizadeh A; Landázuri N; Pantalone MR; Davoudi B; Hu LF; Nawaz I; Stragliotto G; Ekström TJ; Rahbar A
    Oncol Rep; 2019 May; 41(5):2927-2936. PubMed ID: 30896862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Killer cell proteases can target viral immediate-early proteins to control human cytomegalovirus infection in a noncytotoxic manner.
    Shan L; Li S; Meeldijk J; Blijenberg B; Hendriks A; van Boxtel KJWM; van den Berg SPH; Groves IJ; Potts M; Svrlanska A; Stamminger T; Wills MR; Bovenschen N
    PLoS Pathog; 2020 Apr; 16(4):e1008426. PubMed ID: 32282833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of telomerase by human cytomegalovirus.
    Strååt K; Liu C; Rahbar A; Zhu Q; Liu L; Wolmer-Solberg N; Lou F; Liu Z; Shen J; Jia J; Kyo S; Björkholm M; Sjöberg J; Söderberg-Nauclér C; Xu D
    J Natl Cancer Inst; 2009 Apr; 101(7):488-97. PubMed ID: 19318640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human cytomegalovirus may promote tumour progression by upregulating arginase-2.
    Costa H; Xu X; Overbeek G; Vasaikar S; Patro CP; Kostopoulou ON; Jung M; Shafi G; Ananthaseshan S; Tsipras G; Davoudi B; Mohammad AA; Lam H; Strååt K; Wilhelmi V; Shang M; Tegner J; Tong JC; Wong KT; Söderberg-Naucler C; Yaiw KC
    Oncotarget; 2016 Jul; 7(30):47221-47231. PubMed ID: 27363017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.